CSIMarket
 


Genetic Technologies Limited  (GENE)
Other Ticker:  
 

Genetic Technologies Limited's Leverage Ratio

GENE's quarterly Leverage Ratio and Total Liabilities, Equity growth




GENE Leverage Ratio (Jun 30 2019)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Jun 30 2018)
IV. Quarter
Y / Y Equity Change -62.41 % -62.41 % -62.41 % -62.41 % -
Y / Y Total Liabilities Change 2.73 % 2.73 % 2.73 % 2.73 % -
Leverage Ratio MRQ 0.84 0.84 0.84 0.84 0.31
Overall Ranking # # # # #
Seq. Equity Change 0 % 0 % 0 % -62.41 % 0 %
Seq. Total Liabilities Change 0 % 0 % 0 % 2.73 % 0 %



Leverage Ratio forth quarter 2019 Comment
Due to repayements of liabilities of 0% Genetic Technologies Limited improved Leverage Ratio in forth quarter 2019 to 0.84, a new company high.

Within Biotechnology & Pharmaceuticals industry Genetic Technologies Limited achieved lowest Leverage Ratio. While total ranking remained unchanged compare to previous quarter at no. .

Explain Leverage Ratio?
Who are GENE Customers?
Leverage Ratio forth quarter 2019 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall Market # 0


Leverage Ratio Statistics
High Average Low
0.84 0.58 0.31
(Jun 30 2019)   (Jun 30 2018)




Financial Statements
Genetic Technologies Limited's Equity $ 2 Millions Visit GENE's Balance sheet
Genetic Technologies Limited's Total Liabilities $ 1 Millions Visit GENE's Balance sheet
Source of GENE's Sales Visit GENE's Sales by Geography


Cumulative Genetic Technologies Limited's Leverage Ratio

GENE's Leverage Ratio for the trailling 12 Months

GENE Leverage Ratio

(Jun 30 2019)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Jun 30 2018)
IV. Quarter
Y / Y Equity TTM Growth -62.41 % -62.41 % -62.41 % -62.41 % -
Y / Y Total Liabilities TTM Growth 2.73 % 2.73 % 2.73 % 2.73 % -
Leverage Ratio TTM 0.84 0.59 0.45 0.37 0.31
Total Ranking TTM # # # # #
Seq. Equity TTM Growth 0 % 0 % 0 % -62.41 % 0 %
Seq. Total Liabilities TTM Growth 0 % 0 % 0 % 2.73 % 0 %


TTM Leverage Ratio Comment
On the trailing twelve months basis Despite of the repayements of liabilities of 0% in IV. Quarter, Leverage Ratio improved to 0.84, a new company low.
Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Biotechnology & Pharmaceuticals industry GENE recorded the lowest Leverage Ratio. While total ranking remained unchanged compare to previous quarter at no. 0.

Explain Leverage Ratio?
Who are GENE Customers?

TTM Leverage Ratio Company Ranking
Within: No.
Within the Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Within the Market # 0


TTM Leverage Ratio Statistics
High Average Low
0.84 0.84 0.84
(Jun 30 2019)  




Companies with similar Leverage Ratio in the quarter ending Jun 30 2019, within Biotechnology & Pharmaceuticals Industry Leverage RatioJun 30 2019 MRQ Total LiabilitiesJun 30 2019 MRQ Equity
Eyepoint Pharmaceuticals Inc   2.13 $ 59.971  Millions$ 28.210  Millions
Orion Energy Systems Inc   2.07 $ 45.749  Millions$ 22.063  Millions
Enovis Corp  2.05 $ 6,685.057  Millions$ 3,256.349  Millions
Adma Biologics Inc   2.05 $ 96.225  Millions$ 46.906  Millions
Wright Medical Group N v   2.05 $ 1,856.654  Millions$ 906.030  Millions
Htg Molecular Diagnostics Inc  2.01 $ 23.455  Millions$ 11.670  Millions
United Health Products Inc   2.01 $ 0.290  Millions$ 0.145  Millions
Nanostring Technologies Inc   1.67 $ 143.395  Millions$ 85.988  Millions
Collplant Biotechnologies Ltd   1.63 $ 6.664  Millions$ 4.088  Millions
Gilead Sciences Inc   1.63 $ 37,009.000  Millions$ 22,751.000  Millions
Bruker Corporation  1.57 $ 1,363.700  Millions$ 870.100  Millions
Msa Safety Inc  1.49 $ 1,028.802  Millions$ 691.147  Millions
Educational Development Corporation  1.48 $ 39.761  Millions$ 26.871  Millions
Invacare Corporation  1.46 $ 484.903  Millions$ 331.926  Millions
Energy Focus Inc  1.42 $ 8.717  Millions$ 6.152  Millions
Perkinelmer Inc  1.36 $ 3,692.205  Millions$ 2,706.867  Millions
Vaxart Inc   1.35 $ 21.405  Millions$ 15.845  Millions
Conformis inc   1.33 $ 36.297  Millions$ 27.301  Millions
Pacific Biosciences Of California Inc   1.25 $ 94.828  Millions$ 75.754  Millions
Neurocrine Biosciences Inc   1.21 $ 583.155  Millions$ 483.706  Millions
Acorda Therapeutics inc   1.20 $ 652.625  Millions$ 544.837  Millions
Jounce Therapeutics inc   1.12 $ 100.540  Millions$ 90.064  Millions
Zimmer Biomet Holdings Inc   1.08 $ 12,546.600  Millions$ 11,662.200  Millions
Harvard Bioscience Inc  1.04 $ 83.613  Millions$ 80.330  Millions
Biogen Inc   1.03 $ 13,334.700  Millions$ 12,948.800  Millions
Qiagen N v   1.01 $ 2,569.382  Millions$ 2,536.591  Millions
Central Garden and Pet Co  1.00 $ 1,031.273  Millions$ 1,034.323  Millions
Tracon Pharmaceuticals inc   0.96 $ 8.566  Millions$ 8.919  Millions
Meiragtx Holdings Plc  0.95 $ 123.513  Millions$ 129.563  Millions
Alector Inc   0.94 $ 231.535  Millions$ 245.716  Millions

Date modified: 2022-08-31T08:21:00+00:00

Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

INVZ's Profile

Stock Price

INVZ's Financials

Business Description

Fundamentals

Charts & Quotes

INVZ's News

Suppliers

INVZ's Competitors

Customers & Markets

Economic Indicators

INVZ's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071